B. Scherer

发表

PLATELET-MEMBRANE FATTY ACIDS, PLATELET AGGREGATION, AND THROMBOXANE FORMATION DURING A MACKEREL DIET

B. Scherer, P. Weber, W. Siess, 1980, The Lancet.

The binding of atractylate and carboxy-atractylate to mitochondria.

M. Klingenberg, B. Scherer, K. Grebe, 1975, European journal of biochemistry.

Time-dependent changes in prostaglandin excretion in response to frusemide in man.

P. Weber, B. Scherer, 1979, Clinical science.

Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.

P. Weber, B. Scherer, C. Larsson, 1977, European journal of pharmacology.

Prostaglandins and the Regulation of Renin Release: Prostaglandins and the Regulation of Extracellular Fluid Volume

P. Weber, B. Scherer, W. Siess, 1981 .

Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: effect on PG-excretion by PG-synthetase inhibitors, laparotomy and furosemide.

P. Weber, B. Scherer, J. Schnermann, 1978, Prostaglandins.

Renal factors in juvenile hypertension

P. Weber, B. Scherer, 1980, Klinische Wochenschrift.

The role of prostaglandins in essential hypertension.

P. Weber, W. Siess, R. Lorenz, 1981, International journal of obesity.

Prostaglandin excretion after furosemide in normal and low-renin essential hypertension

P. Weber, B. Scherer, H. Witzgall, 1984, Klinische Wochenschrift.

[Reduced urinary prostaglandin E2-excretion and diminished responsiveness of plasma renin activity in patients with essential hypertension (author's transl)].

P. Weber, B. Scherer, E. Held, 1979, Klinische Wochenschrift.

Urinary prostaglandins and kallikrein in essential hypertension.

P. Weber, B. Scherer, E. Held, 1979, Clinical science.

Arachidonic acid metabolites, hypertension and arteriosclerosis

W. Siess, R. Lorenz, B. Scherer, 1982, Klinische Wochenschrift.

A Possible Role of Arachidonic Acid Metabolites in Essential Hypertension

P. Weber, W. Siess, R. Lorenz, 1983 .

Demonstration of the relationship between the adenine nucleotide carrier and the structural changes of mitochondria as induced by adenosine 5'-diphosphate.

M. Klingenberg, B. Scherer, 1974, Biochemistry.

Possible significance of renal prostaglandins in essential hypertension.

P. Weber, W. Siess, B. Scherer, 1980, Clinical and experimental hypertension.

Analysis of 6-keto-prostaglandin F1α in human urine: Age-specific differences

P. Weber, W. Siess, B. Scherer, 1982 .

Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.

P. Weber, B. Scherer, H. Witzgall, 1982, Clinical science.

Renal prostaglandins: Relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants

P. Weber, R. Joppich, B. Scherer, 2004, European Journal of Pediatrics.

Prostacyclin metabolism in adults and neonates Urinary profiles of 6-ketoprostaglandin F1α and 2,3-dinor-6-ketoprostaglandin F1α studied by gas chromatography-mass spectrometry

B. Scherer, S. Fischer, P. Weber, 1983 .

Involvement of Prostaglandins in the Actions of Captopril

P. Weber, B. Scherer, H. Witzgall, 1982 .

Radioimmunological and biological measurement of prostaglandins in rabbit urine: decrease of PGE2 excretion at high NaCl intake.

P. Weber, W. Siess, B. Scherer, 1977, Prostaglandins.

Prostaglandins and hypertension.

P. Weber, B. Scherer, W. Siess, 1984, Advances in experimental medicine and biology.

Possible significance of renal prostaglandins for renin release and blood pressure control.

P. Weber, B. Scherer, J. Schnermann, 1980, Advances in prostaglandin and thromboxane research.

Analysis of 6-keto-prostaglandin F1 alpha in human urine: age-specific differences.

P. Weber, W. Siess, B. Scherer, 1982, Prostaglandins.

Prostaglandin E2-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction

P. Weber, B. Scherer, C. Larsson, 1977, Nature.

Formation and action of prostaglandins in the kidney

P. Weber, B. Scherer, J. Schnermann, 1979, Klinische Wochenschrift.

[Prostaglandins in cardiovascular and renal function. Biochemical, physiological and clinical findings (author's transl)].

P. Weber, W. Siess, B. Scherer, 1979, Klinische Wochenschrift.

The new atractyloside type compound as a high affinity ligand to the adenine nucleotide carrier

M. Klingenberg, P. Riccio, B. Scherer, 1973, FEBS letters.

Prostacyclin metabolites, in urine or adults and neonates, studied by gas chromatography-mass spectrometry and radioimmunoassay.

B. Scherer, P. Weber, S. Fischer, 1982, Biochimica et biophysica acta.

Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F1 alpha and 2,3-dinor-6-ketoprostaglandin F1 alpha studied by gas chromatography-mass spectrometry.

B. Scherer, P. Weber, S. Fischer, 1983, Biochimica et biophysica acta.

Urinary prostaglandins in human neonates: Relationship to kidney function and blood pressure

P. Weber, B. Scherer, K. Holzmann, 1980, Klinische Wochenschrift.

Studies on the mechanism by which ACTH stimulates renin activity and angiotensin II formation in man.

P. Weber, W. Oelkers, B. Scherer, 1982, Acta endocrinologica.

Isolation of a new atractyloside type compound

M. Klingenberg, P. Riccio, B. Scherer, 1973, FEBS letters.

Reversal of “one kidney” to “two kidney” type of goldblatt hypertension in a patient with bilateral renal artery stenosis

P. Weber, E. Uhlich, G. Heberer, 1977, Klinische Wochenschrift.